N-(3-ethylphenyl)-4-(2-methylphenyl)-2-pyridin-4-yl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-6-carboxamide
C28H27N5O — CID 25157951
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(3-ethylphenyl)-4-(2-methylphenyl)-2-pyridin-4-yl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-6-carboxamide
N-(3-ethylphenyl)-4-(2-methylphenyl)-2-pyridin-4-yl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-6-carboxamide (PubChem CID 25157951) has the molecular formula C28H27N5O and a molecular weight of 449.56 g/mol. Its IUPAC name is N-(3-ethylphenyl)-4-(2-methylphenyl)-2-pyridin-4-yl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-6-carboxamide.
Molecular Properties
| Compound Name | N-(3-ethylphenyl)-4-(2-methylphenyl)-2-pyridin-4-yl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-6-carboxamide |
|---|---|
| PubChem CID | 25157951 |
| Molecular Formula | C28H27N5O |
| Molecular Weight | 449.56 g/mol |
| Exact Mass | 449.22 |
| IUPAC Name | N-(3-ethylphenyl)-4-(2-methylphenyl)-2-pyridin-4-yl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-6-carboxamide |
| SMILES | CCc1cccc(NC(=O)N2CCc3nc(-c4ccncc4)nc(-c4ccccc4C)c3C2)c1 |
| InChI | InChI=1S/C28H27N5O/c1-3-20-8-6-9-22(17-20)30-28(34)33-16-13-25-24(18-33)26(23-10-5-4-7-19(23)2)32-27(31-25)21-11-14-29-15-12-21/h4-12,14-15,17H,3,13,16,18H2,1-2H3,(H,30,34) |
| InChIKey | ULLGPFLSMWEVIB-UHFFFAOYSA-N |
| XLogP | 5.67 |
| TPSA | 71.01 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 449.56 |
| LogP ≤ 5 | 5.67 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 25157951 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.